Effect of transcranial magnetic stimulation on prognosis in patients with postherpetic neuralgia and comorbid depression undergoing interventional neuromodulation therapy: protocol for a randomized double-blind placebo-controlled trial - Takeaways - MDSpire

Effect of transcranial magnetic stimulation on prognosis in patients with postherpetic neuralgia and comorbid depression undergoing interventional neuromodulation therapy: protocol for a randomized double-blind placebo-controlled trial

  • By

  • Huichan Xu

  • Yanan Gao

  • Junpeng Yuan

  • Liqun Huang

  • Youjia Yu

  • Xiaohong Jin

  • April 10, 2026

  • 0 min

Share

  • 1

    Postherpetic neuralgia (PHN) often coexists with depression, complicating treatment and worsening patient outcomes.

  • 2

    This study investigates the efficacy of repetitive transcranial magnetic stimulation (rTMS) in improving outcomes for PHN patients with depression.

  • 3

    A total of 174 adult patients will be enrolled in a randomized, double-blind, placebo-controlled trial comparing rTMS to sham stimulation.

  • 4

    Primary outcomes include the incidence of poor prognosis at 3 months post-discharge, with secondary outcomes assessing pain and depression scores.

  • 5

    The study aims to provide preliminary evidence on the safety and effectiveness of rTMS as an adjunct to interventional neuromodulation therapies.

Original Source(s)

Related Content